FutureHealth Podcast Series

Insight by

TD Cowen’s Future Health Podcast, hosted by Charles Rhyee, TD Cowen’s Health Care Technology Analyst, explores the convergence of health care, technology, and consumerism and how it changes the way we look at health care. The podcast bring together thought-leaders, innovators and investors across sectors to get the most up-to-date views on the current landscape.

FutureHealth Podcast Series

  1. Episode 1: Welldoc – Anand Iyer, Chief Strategy Officer: Digital therapeutics hold the potential for a new class of drugs with software as the therapeutic agent. In this podcast, Charles Rhyee, TD Cowen’s Health Care Technology Analyst, speaks with Anand Iyer, Chief Strategy Officer of Welldoc. Mr. Ieyer played a key role in the development of Welldoc’s BlueStar, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes.
  2. Episode 2: Click Therapeutics – David Klein, Co-Founder and CEO: We continue the discussion around digital therapeutics with David Klein, Co-Founder and CEO of Click Therapeutics. Click Therapeutics develops software for mobile phones that uses cognitive and neurobehavioral mechanisms for medical treatment. They discuss partnerships, the effect of regulators and payer reimbursement on the market, and paths to commercialization.
  3. Episode 3: Evidation Health – Deborah Kipatrick, CEO: The biopharma industry, which has always valued and sought out new forms of data has increasingly started looking outside the controlled environment of clinical trials to find data from the real world. One newer form of real-world evidence is everyday behavior data. Charles Rhyee, TDCowen’s Health Care Technology Analyst, is joined by Deborah Kilpatrick, CEO of Evidation Health to help us explore this topic.
  4. Episode 4: Glooko – Russ Johannesson, CEO: Diabetes devices is an industry with exciting long term secular growth. To help us discuss the future of digital diabetes care, we’re joined by Russ Johannesson, CEO of Glooko. Glooko is a SaaS software for diabetes management, enabling seamless aggregation/management of data from various diabetes devices, and increasingly, providing adjacent services to physicians.
  5. Episode 5: Saama Technologies – Suresh Katta, Founder and CEO and Greg Simpson, VP and Head of Marketing: In this episode, we discuss AI-powered data and analytics in clinical development.In the digital age, data and analytics are being applied to just about everything, nowhere more than drug development. The biopharma space is always looking for ways to accelerate and optimize the clinical development process. Charles Rhyee, TDCowen’s Health Care Technology Analyst speaks with Suresh Katta, Founder and CEO, along with Greg Simpson VP and Head of Marketing, of Saama Technologies.
  6. Episode 6: MTBC – Bill Korn, CFO: In this episode, we talk about the role of technology in the provider setting. Technology is playing an increasingly important role in optimizing the workflows and reducing the administrative burdens of providers. Charles Rhyee, TDCowen’s Health Care Technology Analyst, speaks with Bill Korn, CFO of MTBC to help us explore this topic.
  7. Episode 7: Digital Health for Chronic Conditions: A Conversation with the CEO of Omada Health: Charles Rhyee, TDCowen’s Healthcare Technology analyst speaks with Sean Duffy, Co-founder and CEO of Omada Health, a digital care company that supports patients with pre-diabetes, type 2 diabetes, hypertension, behavioral health and musculoskeletal disorders via data-powdered human coaching, connected devices and curriculum. In this episode they discuss digital chronic care management.
  8. Episode 8: Video Game Therapy for Cognitive Impairment: A Conversation with the CEO of Akili Interactive: Charles Rhyee, TDCowen Health Care Technology Analyst, speaks with Eddie Martucci, Co-Founder & CEO of Akili Interactive. They discuss how Akili Interactive provides immersive action interactive video game experiences to treat cognitive impairments including ADHD.
  9. Episode 9: Healthcare Digital Transformation | Heather Cox, Humana’s Chief Digital Health & Analytics Officer: Heather Cox, Chief Digital Health & Analytics Officer of Humana speaks with Charles Rhyee, TDCowen Health Care Technology Analyst about the parallels between the digitization of financial services and healthcare and how lessons learned in financial services can improve healthcare technology and increase patient convenience.
  10. Episode 10: The Outlook for Telehealth and Virtual Care at the Cleveland Clinic: Dr. Peter Rasmussen, Chief Clinical Officer of the Cleveland Clinic/AmWell Digital Health Joint Venture joins Charles Rhyee, Healthcare Technology Analyst. They discuss the origin of telehealth at Cleveland Clinic, the drivers for adoption, and continued growth during the COVID-19 pandemic.
  11. Episode 11: reSET-ing the Treatment Paradigm for Mental Health: Corey McCann, MD, PhD, President and CEO of Pear Therapeutics, joined Charles Rhyee, Health Care Technology Analyst. Pear Therapeutics is a pioneer in prescription digital therapeutics. It is the first company to receive FDA market authorization for software to treat disease.
  12. Episode 12: The Need for New Models of Primary Care: Scott Shreeve, MD, Co-Founder and CEO of Crossover Health, a patient-centered, membership-based medical group that is redesigning the practice, delivery and experience of health care joined Charles Rhyee, Health Care Technology Analyst to discuss how the use of technology can move us from reactive sick-care to proactive well-care.
  13. Episode 13: The Right Way to Access Care: Jordan Feldman, Co-Founder and CEO of Rightway Healthcare speaks with Charles Rhyee, Health Care Technology & Distribution Analyst about the complexities of healthcare and how technology can help patients effectively navigate this ecosystem and reduce cost of care.
  14. Episode 14: The Convergence of Virtual & In-Person Health Care: Ido Schoenberg, MD Chairman and CEO of Amwell speaks with Charles Rhyee, TDCowen Health Care Technology Analyst about how COVID-19 has changed the perception of telehealth, how virtual care is evolving beyond simply on-demand care, and how Amwell’s new platform,  Converge, connects virtual care into the existing physical healthcare world to create a new model for care delivery.
  15. Episode 15: Raising the Bar for Employee Benefits with Ali Diab, CEO, Collective Health: TDCowen’s Health Care Technology analyst Charles Rhyee speaks with Ali Diab, Co-Founder and CEO of Collective Health. They talk about how Collective Health creates a seamless and positive user experience for consumers, while helping employers manage their employee benefit plans.
  16. Episode 16: Rehumanizing Doctor-Patient Relationships with Manny Krakaris, CEO, Augmedix: TDCowen’s Health Care Technology analyst Charles Rhyee speaks with Manny Krakaris, CEO of Augmedix. Augmedix is a pioneer in medical note documentation that is estimated to save clinicians 2-3 hours per day, increase productivity and improve clinicians’ work-life balance.
  17. Episode 17: Making Healthcare More Affordable with Doug Hirsch, Co-Founder & CEO, GoodRx: Doug Hirsch, Co-Founder & CEO of GoodRx speaks with Health Care Technology Analyst Charles Rhyee about the problems of access and affordability in healthcare, as well as how GoodRx’s offerings help patients find prescriptions at the lowest prices and increase patient access to care. 
  18. Episode 18: Recap of Cowen’s 6th Annual FutureHealth Conference with Steve Blumenfield: Steve Blumenfield, Head of Strategy and Innovation for Health and Benefits North America at Willis Towers Watson and host of the Cure for the Common Co podcast speaks with Charles Rhyee, Health Care Technology Analyst. Together they take a look back at this year’s 6th Annual Cowen FutureHealth Conference, held virtually this past June. 
  19. Episode 19: Data-Enabling Health Care: Charles Rhyee, Health Care Technology Analyst speaks with Jean Drouin, CEO and Founder of Clarify Health. They discuss the digitization of healthcare data in the past decade, early efforts into data analytics and population health, as well as challenges that still remain. 
  20. Episode 20: Tech-Enabling Your Baby with Kurt Workman, Owlet CEO & Co-Founder: Kurt Workman, CEO and Co-Founder of Owlet Baby Care speaks with Charles Rhyee, TDCowen’s Health Care Technology Analyst about the challenges that new parents face after leaving the hospital and how technology is incorporated into products geared for children, particularly in the areas of safety and monitoring. 
  21. Episode 21: The New Infrastructure of Caregiving with Wellthy’s CEO: Lindsay Jurist-Rosner, CEO and Co-Founder of Wellthy speaks with Charles Rhyee, Health Care Technology Analyst about caregiving and the challenges families face today in finding the services they need for their loved ones, which have only been further exacerbated by the pandemic.
  22. Episode 22: Regulatory Outlook for Telehealth: Krista Drobac, Executive Director of the Alliance for Connected Care, a telehealth industry trade group speaks with Charles Rhyee, Health Care Technology & Distribution Analyst about the regulatory outlook for telehealth, including work towards extending current federal rules to expand access to telehealth during the current public health emergency and state level efforts on expanding medical licensure flexibilities. 
  23. Episode 23: On the Road to Interoperability with ONC’s Micky Tripathi: Micky Tripathi, National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services joins the Cowen Insights podcast where he speaks with Charles Rhyee, Health Care Technology Analyst and Eric Assaraf, Health Care Policy Analyst. They discuss interoperability in health care, or how data can be more easily shared among stakeholders. 
  24. Episode 24: Tackling Mental Health With Happify Health’s Ofer Leidner: Ofer Leidner, Co-Founder and President of Happify Health, and Charles Rhyee, Health Care Technology Analyst discuss treating mental health with personalized digital therapeutics and its implications for treating chronic conditions.
  25. Episode 25: Reversing Type 2 Diabetes with Virta Health’s Sami Inkinen: Sami Inkinen, Founder and CEO of Virta Health, an innovative digital health company that helps patients reverse type 2 diabetes through digital therapeutics & nutritional behavior change speaks with health care technology analyst, Charles Rhyee about reversing type 2 diabetes by addressing root causes of the disease and the implications that would have on chronic condition management.
  26. Episode 26: Transforming Care With Transcarent’s Glen Tullman: Glen Tullman, Chairman and CEO of Transcarent joins Health Care Technology Analyst Charles Rhyee to look at how the U.S. healthcare system struggles to deliver better outcomes while spending spirals upwards and explore a better way of leveraging technology to connect directly to providers and deliver high quality but lower-cost care.
  27. Episode 27: Righting The Gut-Brain Connection With Mahana Therapeutics’ Steven Basta: Steven Basta, CEO of Mahana Therapeutics, joins Charles Rhyee, Health Care Technology Analyst to discuss the strong connection between the gut & the brain for those suffering from IBS, and how it is now possible to treat IBS digitally.
  28. Episode 28: Solving The Lack of Diversity In Clinical Trials With Acclinate’s Del Smith: Del Smith, Co-Founder and CEO of Acclinate, joins Health Care Technology Analyst Charles Rhyee to discuss Acclinate’s mission to educate and engage diverse individuals in order to help them make informed decisions about genomic research and clinical trial participation.
  29. Episode 29: Digital’s Role in Tomorrow’s Care Delivery with Ken Ehlert: Ken Ehlert, Former Chief Scientific Officer of UnitedHealth Group, joins Charles Rhyee, Cowen’s Health Care Technology Analyst to discuss how the delivery of care is shifting from hospitals & doctor’s offices to our homes and smart devices.
  30. Episode 30: Delivering Precision Medicare With HealthIQ’s Mujal Shah: Munjal Shah, CEO and Co-Founder of HealthIQ speaks with Charles Rhyee, Cowen’s Health Care Technology Analyst about empowering patients to make better decisions by using their own health information.
  31. Episode 31: Disrupting The Traditional Clinical Trial Model: David Fishbach, Founder & Principal of Excel Executive Business Advisors, which provides corporate strategy, operations, and leadership development for technology, life sciences, and healthcare joins Charles Rhyee, Cowen’s Health Care Technology Analyst to discuss the evolution of the clinical research landscape, how technology addresses inefficiencies in the traditional site-based clinical trial based process, and how it counters the rising cost of developing new therapies.
  32. Episode 32: Outlook For Clinical Drug Development and Outsourcing With Rene Stephens: Over the last decade, contract research organizations (CROs) have become an increasingly important stakeholder in the clinical trial process with over half of biopharma R&D budgets outsourced to them. Rene and Charles discuss whether CROs can innovate their people-intensive processes to improve drug development costs and timelines moving forward.
  33. Episode 33: Navigating Better Outcomes With Quantum Health’s Zane Burke: Zane Burke, CEO of Quantum Health and former CEO of Livongo joins Charles Rhyee, TD Cowen Health Care Technology Analyst. They discuss how to navigate the plethora of digital health healthcare delivery options that have emerged over the past 5-10 years.
  34. Episode 34: Why Aren’t We Using Telehealth Anymore?: Dr. William Morris, former Executive Medical Director of Cleveland Clinic Innovations and Ventures and current member of the Cleveland Clinic Board of Governors and Google Cloud’s Healthcare and Life Sciences Solutions business, joins Charles Rhyee, TD Cowen’s Health Care Technology Analyst. Together they try and answer the question, what’s going on with telehealth, or more exactly, what’s not going on with telehealth? 
  35. Episode 35: Understanding And Leveraging Healthcare Data: Paul Reuscher, vice president of clinical data products at Forian joins Charles Rhyee, health care technology analyst. They discuss how data and analytics have become increasingly engrained in the health care system over the last decade and focus on how healthcare data is currently being used. Given the evolving landscape, they provide a deeper look into the different types of health care data currently available, as well as the users and use cases.
  36. Episode 36: Employer Strategies for Managing GLP1s With Industry Expert Vaughan Reale: This episode of the FutureHealth Podcast Series covers the evolving prescription benefit landscape and takes a deeper look into how plan sponsors can navigate important decisions in coverage and access.
  37. Episode 37: Rethinking The Management Of Pharmacy Benefits With Waltz Health: Mark Thierer, Co-Founder and CEO of Waltz Health, and Jeff Park, President of Waltz Health join Charles Rhyee, Health Care Technology Analyst. They discuss the pharmacy benefit management (PBM) industry, which has been instrumental in managing down the cost of prescription drugs and healthcare.
  38. Episode 38: The Evolving Landscape Of Pharmacy Reimbursement – In this episode we take a look at the changing landscape for pharmacy reimbursement and the push towards a cost-plus model of reimbursement. We’re joined by Michael Rothrock, who brings over 20 years of experience within both the managed care and PBM industry. Before starting Allegheny Strategic Partners, Mr. Rothrock was the VP of Pharma Strategy and Contracting at Express Scripts.

Episode 1: Welldoc – Anand Iyer, Chief Strategy Officer

Digital therapeutics hold the potential for a new class of drugs with software as the therapeutic agent. In this podcast, Charles Rhyee, TD Cowen’s Health Care Technology Analyst, speaks with Anand Iyer, Chief Strategy Officer of Welldoc. Mr. Ieyer played a key role in the development of Welldoc’s BlueStar, the first FDA-cleared mobile prescription therapy for adults with type 2 diabetes. They discuss the adoption of digital therapeutics, challenges to achieving a successful commercial model, and COVID-19’s impact on consumer and physician readiness to adopt telehealth and digital care.

For the full transcript click here

Episode 2: Click Therapeutics – David Klein, Co-Founder and CEO

We continue the discussion around digital therapeutics with David Klein, Co-Founder and CEO of Click Therapeutics. Click Therapeutics develops software for mobile phones that uses cognitive and neurobehavioral mechanisms for medical treatment. They discuss partnerships, the effect of regulators and payer reimbursement on the market, and paths to commercialization.

For the full transcript click here

Episode 3: Evidation Health – Deborah Kipatrick, CEO

The biopharma industry, which has always valued and sought out new forms of data has increasingly started looking outside the controlled environment of clinical trials to find data from the real world. One newer form of real-world evidence is everyday behavior data. Charles Rhyee, Cowen’s Health Care Technology Analyst, is joined by Deborah Kilpatrick, CEO of Evidation Health to help us explore this topic. Evidation is a new kind of health and measurement company that focuses on capturing and measuring everyday behavior data, which is proving to be an exceptionally powerful lens on health. They discuss privacy and permission for use of data streams, partnerships in pharma, medtech and technology, and how Evidation is helping research the impact of and susceptibility to COVID-19.

For the full transcript click here

Episode 4: Glooko – Russ Johannesson, CEO

Diabetes devices is an industry with exciting long term secular growth. To help us discuss the future of digital diabetes care, we’re joined by Russ Johannesson, CEO of Glooko. Glooko is a SaaS software for diabetes management, enabling seamless aggregation/management of data from various diabetes devices, and increasingly, providing adjacent services to physicians. They discuss market opportunity and penetration, evolution of the product offering, the competitive landscape, and how partnerships help with Glooko’s long term vision.

For the full transcript click here

Episode 5: Saama Technologies – Suresh Katta, Founder and CEO and Greg Simpson, VP and Head of Marketing

In this episode, we discuss AI-powered data and analytics in clinical development.In the digital age, data and analytics are being applied to just about everything, nowhere more than drug development. The biopharma space is always looking for ways to accelerate and optimize the clinical development process. Charles Rhyee, Cowen’s Health Care Technology Analyst speaks with Suresh Katta, Founder and CEO, along with Greg Simpson VP and Head of Marketing, of Saama Technologies. Saama Technologies is a clinical data analytics company that leverages AI to integrate, curate and animate structured, unstructured and real-world data to deliver actionable insights for biopharma.

For the full transcript click here

Episode 6: MTBC – Bill Korn, CFO

In this episode, we talk about the role of technology in the provider setting. Technology is playing an increasingly important role in optimizing the workflows and reducing the administrative burdens of providers. Charles Rhyee, Cowen’s Health Care Technology Analyst, speaks with Bill Korn, CFO of MTBC to help us explore this topic. MTBC is a health information technology company that helps customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. They discuss revenue cycle management, the current M&A landscape, robotic process automation (RPA), artificial intelligence (AI), and adaptations to COVID-19.

For the full transcript click here

Episode 7: Digital Health for Chronic Conditions: A Conversation with the CEO of Omada Health

Charles Rhyee, Cowen’s Healthcare Technology analyst speaks with Sean Duffy, Co-founder and CEO of Omada Health, a digital care company that supports patients with pre-diabetes, type 2 diabetes, hypertension, behavioral health and musculoskeletal disorders via data-powdered human coaching, connected devices and curriculum. In this episode they discuss digital chronic care management, Omada’s partnership with Abbott Laboratories, the impact of COVID-19 on remote telehealth, and a randomized trial on diabetes prevention through digital health and coaching.

For the full transcript click here

Episode 8: Video Game Therapy for Cognitive Impairment: A Conversation with the CEO of Akili Interactive

Charles Rhyee, Cowen Health Care Technology Analyst, speaks with Eddie Martucci, Co-Founder & CEO of Akili Interactive. In this episode they discuss how Akili Interactive provides immersive action interactive video game experiences to treat cognitive impairments including ADHD. They speak about how this treatment augments the current standard of care and how it targets cognitive function and strengthens neural connectivity. In addition, they also discuss focusing on distribution rather than volume, current patient interest, and payer coverage.

For the full transcript click here

Episode 9: Healthcare Digital Transformation | Heather Cox, Humana’s Chief Digital Health & Analytics Officer

Heather Cox, Chief Digital Health & Analytics Officer of Humana speaks with Charles Rhyee, Cowen Health Care Technology Analyst. They discuss the parallels between the digitization of financial services and healthcare and how lessons learned in financial services can improve healthcare technology and increase patient convenience.

They also speak about how Humana is leveraging technology to improve patient experiences and care for diverse populations through a focus on data security, combining enterprise data lakes with machine learning to uncover insights, and simplifying digital health platforms to improve the healthcare experience.

For the full transcript click here

Episode 10: The Outlook for Telehealth and Virtual Care at the Cleveland Clinic

Dr. Peter Rasmussen, Chief Clinical Officer of the Cleveland Clinic/AmWell Digital Health Joint Venture joins Charles Rhyee, Healthcare Technology Analyst. They discuss the origin of telehealth at Cleveland Clinic, the drivers for adoption, and continued growth during the COVID-19 pandemic. They also speak about how the nonenforcement of state licensure agreements amid COVID-19 has affected telehealth & the biggest obstacles to digital health adoption.

For the full transcript click here

Episode 11: reSET-ing the Treatment Paradigm for Mental Health | Corey McCann, MD, PhD, President and CEO, Pear Therapeutics

Charles Rhyee, Health Care Technology Analyst speaks with Corey McCann, MD, PhD, President and CEO of Pear Therapeutics. Pear Therapeutics is a pioneer in prescription digital therapeutics. It is the first company to receive FDA market authorization for software to treat disease.

They discuss the impact of COVID-19 on mental health, the challenges of getting individuals treatment during the pandemic and how software can serve as front-line treatment for a wide range of conditions for the first time. This includes substance use disorder, opiate use disorder and chronic insomnia. Their conversation delves into the advantages that a digital therapeutics platform has over traditional drug development. They also speak about the unique challenges and opportunities of launching a whole new class of drugs in this difficult period.

For the full transcript click here

Episode 12: The Need for New Models of Primary Care | Scott Shreeve, Co-Founder & CEO, Crossover Health

Cowen’s Health Care Technology analyst Charles Rhyee speaks with Scott Shreeve, MD, Co-Founder and CEO of Crossover Health, a patient-centered, membership-based medical group that is redesigning the practice, delivery and experience of health care. An emergency medicine physician by training, Scott has spent his career actively building life science technologies that improve the delivery of care and enhance the quality of life. They discuss the problems with primary care today and why we have seen the emergence of new models of primary care in recent years. They speak about how the use of technology can move us from reactive sick-care to proactive well-care. They also discuss the outlook for primary care and the changing role of physicians in delivering care. Press play to listen to their conversation.

For the full transcript click here

Episode 13: The Right Way to Access Care | Rightway Healthcare CEO, Jordan Feldman

Jordan Feldman, Co-Founder and CEO of Rightway Healthcare speaks with Charles Rhyee, Health Care Technology & Distribution Analyst. They discuss the complexities of healthcare and how technology can help patients effectively navigate this ecosystem and reduce cost of care. They also discuss the impact of COVID-19 on how employers think of the benefits they offer. Press play to listen to their conversation.

For the full transcript click here

Episode 14: The Convergence of Virtual & In-Person Health Care | Amwell Chairman & CEO, Ido Schoenberg

Ido Schoenberg, MD Chairman and CEO of Amwell speaks with Charles Rhyee, Cowen Health Care Technology Analyst. They discuss how COVID-19 has changed the perception of telehealth, how virtual care is evolving beyond simply on-demand care, and how Amwell’s new platform, Converge, connects virtual care into the existing physical healthcare world to create a new model for care delivery.

For the full transcript click here

Episode 15: Raising the Bar for Employee Benefits with Ali Diab, CEO, Collective Health

Cowen’s Health Care Technology analyst Charles Rhyee speaks with Ali Diab, Co-Founder and CEO of Collective Health. They talk about how Collective Health creates a seamless and positive user experience for consumers, while helping employers manage their employee benefit plans. They also discuss the outlook for virtual care and ways that COVID-19 has changed how employers think about their benefit packages.

For the full transcript click here

Episode 16: Rehumanizing Doctor-Patient Relationships with Manny Krakaris, CEO, Augmedix

Cowen’s Health Care Technology analyst Charles Rhyee speaks with Manny Krakaris, CEO of Augmedix. Augmedix is a pioneer in medical note documentation that is estimated to save clinicians 2-3 hours per day, increase productivity and improve clinicians’ work-life balance.

They discuss the administrative burden of medical note documentation on providers today and how Augmedix’s offerings can increase productivity and prevent physician burnout. They also talk about how Augmedix leverages technology, such as AI, machine learning, and natural language processing, to create value for health systems and physicians.

For the full transcript click here

Episode 17: Making Healthcare More Affordable with Doug Hirsch, Co-Founder & CEO, GoodRx

Doug Hirsch, Co-Founder & CEO of GoodRx speaks with Charles Rhyee, Health Care Technology Analyst Charles Rhyee. They discuss the problems of access and affordability in healthcare, as well as how GoodRx’s offerings help patients find prescriptions at the lowest prices and increase patient access to care. Press play to listen to the podcast.

Doug co-founded GoodRx in 2011. The company provides access to price transparency and affordable solutions for generic and brand medications. This has saved Americans $30 billion on prescription medications since its founding. They also provide affordable and convenient medical provider consultations via telehealth.

Doug has spent decades building technology that helps everyday consumers, starting as one of the first employees at Yahoo! before moving onto Facebook as VP of Product, and then founding DailyStrength.

For the full transcript click here

Episode 18: Recap of Cowen’s 6th Annual FutureHealth Conference with Steve Blumenfield

Steve Blumenfield, Head of Strategy and Innovation for Health and Benefits North America at Willis Towers Watson and host of the Cure for the Common Co podcast speaks with Charles Rhyee, Health Care Technology Analyst.

Together they take a look back at this year’s 6th Annual Cowen FutureHealth Conference, held virtually this past June. They discuss the wide range of topics covered during the conference, including telehealth, chronic care management, women’s health, and caregiving. As part of his role at Willis Towers Watson, Steve Blumenfield helps develop high potential new practice areas and curates the digital health and benefit landscape for clients.

For the full transcript click here

Episode 19: Data-Enabling Health Care | Clarify Health CEO & Founder, Jean Drouin

In this episode, Charles Rhyee, Health Care Technology Analyst speaks with Jean Drouin, CEO and Founder of Clarify Health. Clarify Health is a healthcare analytics platform that uses comprehensive, longitudinal and linked data from clinical, claims, prescription, lab, and consumer data sources to inform thousands of predictive models and streamline decision-making for payors, health plans, and pharma.

They discuss the digitization of healthcare data in the past decade, early efforts into data analytics and population health, as well as challenges that still remain. They also explore how Clarify Health combines unique and detailed datasets with a technology stack that drives value for payors, providers and pharma. Clarify enables payors and providers to adopt risk-based contracts by offering data-driven insights into patient populations. Lastly, they discuss the future of our healthcare system and the role that data can play in addressing problems exposed by the COVID-19 pandemic.

For the full transcript click here

Episode 20: Tech-Enabling Your Baby with Kurt Workman, Owlet CEO & Co-Founder

Kurt Workman, CEO and Co-Founder of Owlet Baby Care speaks with Charles Rhyee, Cowen’s Health Care Technology Analyst. They discuss the challenges that new parents face after leaving the hospital and how technology is incorporated into products geared for children, particularly in the areas of safety and monitoring. They also explore how the traditionally consumer category of baby products is slowly making the shift into the healthcare arena.

For the full transcript click here

Episode 21: The New Infrastructure of Caregiving with Wellthy’s CEO

When most people talk about health care, they tend to speak about it in terms of themselves: How do I as the individual use the healthcare system? How do I interact with my insurance company? How do I use this digital health app? But oftentimes, a lot of care is coordinated not by the individual but by others.

In this episode, Lindsay Jurist-Rosner, CEO and Co-Founder of Wellthy speaks with Charles Rhyee, Health Care Technology Analyst. They discuss caregiving and the challenges families face today in finding the services they need for their loved ones, which have only been further exacerbated by the pandemic. They also explore how technology can create a new infrastructure for caregiving.

For the full transcript click here

Episode 22: Regulatory Outlook for Telehealth

In this episode, Krista Drobac, Executive Director of the Alliance for Connected Care, a telehealth industry trade group speaks with Charles Rhyee, Health Care Technology & Distribution Analyst. 

They discuss the regulatory outlook for telehealth, including work towards extending current federal rules to expand access to telehealth during the current public health emergency and state level efforts on expanding medical licensure flexibilities. In addition, they also talk about the application of telehealth as more care, in general, is being delivered in the home and the needed regulatory changes required to enable that shift.

For the full transcript click here

Episode 23: On the Road to Interoperability with ONC’s Micky Tripathi

Micky Tripathi, National Coordinator for Health Information Technology at the U.S. Department of Health and Human Services joins the Cowen Insights podcast where he speaks with Charles Rhyee, Health Care Technology Analyst and Eric Assaraf, Health Care Policy Analyst. Mr. Tripathi leads the formulation of the federal health IT strategy and coordinates federal health IT policies, standards, programs, and investments.

In this episode, they we discuss interoperability in health care, or how data can be more easily shared among stakeholders. This has been a unique problem in healthcare, but over the last decade efforts have been underway to resolve that problem first through the HITECH Act and then through the 21st Century Cures Act.

For the full transcript click here

Episode 24: Tackling Mental Health With Happify Health’s Ofer Leidner

Ofer Leidner, Co-Founder and President of Happify Health, and Charles Rhyee, Health Care Technology Analyst discuss treating mental health with personalized digital therapeutics and its implications for treating chronic conditions. They also discuss how Happify’s intelligent healing platform uses gamification to engage users and effectuate behavior change.

For the full transcript click here

Episode 25: Reversing Type 2 Diabetes with Virta Health’s Sami Inkinen

Sami Inkinen, Founder and CEO of Virta Health, an innovative digital health company that helps patients reverse type 2 diabetes through digital therapeutics & nutritional behavior change joins the Cowen Insights podcast. He speaks with health care technology analyst, Charles Rhyee about reversing type 2 diabetes by addressing root causes of the disease and the implications that would have on chronic condition management.

For the full transcript click here

Episode 26: Transforming Care With Transcarent’s Glen Tullman

Glen Tullman, Chairman and CEO of Transcarent joins Health Care Technology Analyst Charles Rhyee. Together they look at how the U.S. healthcare system struggles to deliver better outcomes while spending spirals upwards and explore a better way of leveraging technology to connect directly to providers and deliver high quality but lower-cost care.

For the full transcript click here

Episode 27: Righting The Gut-Brain Connection With Mahana Therapeutics’ Steven Basta

Steven Basta, CEO of Mahana Therapeutics, discusses the strong connection between the gut & the brain for those suffering from IBS, and how it is now possible to treat IBS digitally. Mahana IBS is the first FDA-approved prescription digital therapeutic for IBS treatment. It uses cognitive behavioral therapy, or CBT, to help people build a healthier brain-gut relationship. The results are decreased symptom severity and increase overall well-being.

For the full transcript click here

Episode 28: Solving The Lack of Diversity In Clinical Trials With Acclinate’s Del Smith

Del Smith, Co-Founder and CEO of Acclinate, discusses Acclinate’s mission to educate and engage diverse individuals in order to help them make informed decisions about genomic research and clinical trial participation. According to the CDC, of the mere 5% of Americans that participate in clinical research trials, 76% are white, 7% are black, 11% are Asian, and only 13% identify as Hispanic. In other words, not only do very few people get to participate in clinical trials, but minorities are woefully underrepresented. Thankfully, that is beginning to change as new companies emerge to help drug makers improve access and champion diversity in clinical research that is potentially lifesaving.

For the full transcript click here

Episode 29: Digital’s Role in Tomorrow’s Care Delivery with Ken Ehlert

Ken Ehlert, Former Chief Scientific Officer of UnitedHealth Group, joins Charles Rhyee, Cowen’s Health Care Technology Analyst. With over three decades of experience in health care, Ken has focused on using data, analytics, and a longitudinal understanding of disease to build products and businesses that improve the healthcare system. They discuss how the delivery of care is shifting from hospitals & doctor’s offices to our homes and smart devices. They also speak about the rapid pace of innovation and how it has spawned new entrants in the field.

For the full transcript click here

Episode 30: Delivering Precision Medicare With HealthIQ’s Mujal Shah

Munjal Shah, CEO and Co-Founder of HealthIQ speaks with Charles Rhyee, Cowen’s Health Care Technology Analyst about empowering patients to make better decisions by using their own health information.

In 2022, more than 28M people enrolled in a Medicare Advantage plan. That number has been growing 8% every year since 2010. But how effective is the industry at placing patients into the plan that best suits their personal needs? HealthIQ aims to start using a senior’s detailed health records to find the precise Medicare Advantage plan that is most personalized to their needs and will best support their health in the coming years, in what the company calls Precision Medicare.

For the full transcript click here

Episode 31: Disrupting The Traditional Clinical Trial Model

David Fishbach, Founder & Principal of Excel Executive Business Advisors, which provides corporate strategy, operations, and leadership development for technology, life sciences, and healthcare joins Charles Rhyee, Cowen’s Health Care Technology Analyst in this episode. David’s career has included past leadership experience with many technology companies that serve the biopharma industry including Veeva Systems, Oracle Health Services and PhaseForward.

They discuss the evolution of the clinical research landscape, how technology addresses inefficiencies in the traditional site-based clinical trial based process, and how it counters the rising cost of developing new therapies. They also discuss the FDA’s favorable views on technology-enabled and decentralized clinical trial models, and its potential disrupt the industry by addresses some longstanding issues in research, including a lack of accessibility & diversity.

For the full transcript click here

Episode 32: Outlook For Clinical Drug Development and Outsourcing With Rene Stephens

Rene Stephens of Renatus Consulting, an independent advisory to contract research organization (CRO) and life science clients, speaks with Charles Rhyee, Health Care Technology Analyst. Over the last decade, contract research organizations (CROs) have become an increasingly important stakeholder in the clinical trial process with over half of biopharma R&D budgets outsourced to them. Rene and Charles discuss whether CROs can innovate their people-intensive processes to improve drug development costs and timelines moving forward.

For the full transcript click here

Episode 33 Navigating Better Outcomes With Quantum Health’s Zane Burke

Zane Burke, CEO of Quantum Health and former CEO of Livongo joins Charles Rhyee, TD Cowen Health Care Technology Analyst. They discuss how to navigate the plethora of digital health healthcare delivery options that have emerged over the past 5-10 years.

For the full transcript click here

Episode 34 Why Aren’t We Using Telehealth Anymore? 

In this episode of TD Cowen’s FutureHealth Podcast Series, Dr. William Morris, former Executive Medical Director of Cleveland Clinic Innovations and Ventures and current member of the Cleveland Clinic Board of Governors and Google Cloud’s Healthcare and Life Sciences Solutions business, joins Charles Rhyee, TD Cowen’s Health Care Technology Analyst. Together they try and answer the question, what’s going on with telehealth, or more exactly, what’s not going on with telehealth? 

For the full transcript click here

Episode 35 Understanding And Leveraging Healthcare Data

Paul Reuscher, vice president of clinical data products at Forian joins Charles Rhyee, health care technology analyst. They discuss how data and analytics have become increasingly engrained in the health care system over the last decade and focus on how healthcare data is currently being used. Given the evolving landscape, they provide a deeper look into the different types of health care data currently available, as well as the users and use cases.

For the full transcript click here

Episode 36 Employer Strategies for Managing GLP1s With Industry Expert Vaughan Reale

This episode covers the evolving prescription benefit landscape and takes a deeper look into how plan sponsors can navigate important decisions in coverage and access.

For the full transcript click here

Episode 37: Rethinking The Management Of Pharmacy Benefits With Waltz Health

Episode 38: The Evolving Landscape Of Pharmacy Reimbursement

In this episode we take a look at the changing landscape for pharmacy reimbursement and the push towards a cost-plus model of reimbursement. We’re joined by Michael Rothrock, who brings over 20 years of experience within both the managed care and PBM industry. Before starting Allegheny Strategic Partners, Mr. Rothrock was the VP of Pharma Strategy and Contracting at Express Scripts, where he was responsible for leading commercial and Medicare formulary contracting and strategy.

For the full transcript click here


Get the Full Report

If you’re already a member of our Research portal, log in.

Log In

If not, reach out to us directly for more information.